The mecA-27r gene from Staphylococcus aureus 27r encodes penicillin-binding protein 2a (PBP2a-27r), which causes this strain to be methicillin resistant. Removal or replacement of the N-terminal transmembrane domain had no effect on binding of penicillin, but removal of portions of the putative transglycosylase domain (144, 245, or 341 amino acids after the transmembrane region) destroyed penicillin-binding activity. The SXXK, SXN, and KSG motifs, present in all penicillin-interacting enzymes, were found in the expected linear spatial arrangement within the putative transpeptidase region of PBP2a-27r. Alterations of amino acids in all three of these motifs resulted in elimination of penicillin-binding activity, confirming their roles in the interaction with penicillin.
The emergence of Staphylococcus aureus strains resistant to methicillin and other beta-lactam antibiotics occurred shortly after the introduction of methicillin into clinical use (8) . Methicillin-resistant S. aureus and Staphylococcus epidermidis cause serious nosocomial infections in patients whose resistance to colonization has been compromised. Such nosocomial infections represent a significant cause of morbidity and mortality in hospitals and chronic care facilities (7, 17) .
Resistance to methicillin in clinical isolates of staphylococci is mediated by a novel high-molecular-weight penicillin-binding protein (PBP) referred to as PBP2a (1, 5, 6, 24) . This membrane-bound protein is a unique cell wall-synthesizing enzyme possessing low affinity for beta-lactam antibiotics (21) . Because of this uncharacteristically low affinity for beta-lactams, PBP2a can apparently compensate for the transpeptidation function of all other PBPs in staphylococci and allow survival in the presence of otherwise lethal concentrations of beta-lactams (14) . Staphylococci growing in the presence of methicillin express PBP2a, which causes an alteration in the cell wall architecture by reducing the cross-linking in peptidoglycan (2, 3, 15, 32, 35) .
PBP2a is encoded by the mecA gene, which is highly conserved in all clinical isolates of staphylococci that are methicillin-resistant (18, 25, 28, 33) . Geographically distinct methicillin-resistant staphylococcal isolates from Japan, the United States, and Europe (including S. aureus and S. epidermidis) were more than 99% identical in their respective mecA DNA sequences (25, 33) . The mecA gene is not present in clinical isolates of methicillin-susceptible staphylococci (31) , suggesting that mecA was obtained by genetic transfer from another species rather than by alteration of an endogenous PBP-encoding gene. The results of a recent epidemiological study are consistent with a clonal origin of methicillin resistance in the staphylococci followed by rapid spread to related staphylococcal species (12) . The source of the mecA gene remains unidentified.
Analysis of the amino acid sequence of PBP2a deduced from the DNA sequence revealed specific motifs common to penicillin-interacting enzymes (25, 28, 33) . The functional significance of these motifs has not been tested in PBP2a. Song and coworkers (28) suggested that PBP2a is composed of two domains-an N-terminal transglycosylase domain followed by a transpeptidase domain. However, the actual function and interdependence of the domains have not been explored. Functional analysis of conserved motifs in PBP2a, as well as investigation of the relationship between domains, may be useful in a structure-based drug design program aimed at developing inhibitors of PBP2a. This communication describes a series of site-specific mutagenesis experiments that were designed to probe the effect of the transglycosylase domain on penicillin-binding activity as well as the significance of conserved motifs in PBP2a-27r.
MATERIALS AND METHODS
Plasmids, genes, and bacterial strains. The plasmids used in various aspects of this study are described briefly in Results and are listed in Fig. 3 and 4 . The starting plasmid used for soluble expression of PBP2a-27r in E. coli contained a Bacillus subtilis vegetative promoter controlling expression of the mecA-27r gene (19) and a kanamycin resistance gene for maintenance in E. coli. The mecA-27r gene was described in a previous study (33 (10, 27) . Addition of the chelating peptide to PBP2a-27r did not significantly alter its ability to bind penicillin and provided a useful molecular handle for protein purification.
Removal of the transmembrane region and addition of the chelating peptide without detrimental effect on penicillin binding suggested that the putative transglycosylase domain might not be critical to penicillin-binding activity. These observations prompted an investigation into whether all or a portion of the transglycosylase-like domain might be removed from PBP2a-27r without loss of penicillin-binding activity. If a shortened version of this protein retained penicillin-binding activity and crystallized more readily than the full-length protein, then useful structural information on the active site of the putative transpeptidase domain might be obtained more easily.
Effect of removal of the putative transglycosylase domain of PBP2a-27r on penicillin-binding activity. The beginning of the transglycosylase-like domain of PBP2a-27r was assumed to be located adjacent to the membrane-spanning region and to continue to roughly amino acid residue 341, the presumed beginning of the transpeptidase-like domain. The beginning of the transpeptidase region was estimated by counting back 60 amino acids from the SXXK motif, which is typically found 60 amino acids from the N terminus of a transpeptidase (9) .
Site-specific in vitro mutagenesis was used to alter the mecA-27r gene by inserting an NcoI restriction site in frame with the open reading frame of PBP2a-27r at four different positions within the putative transglycosylase domain. The NcoI restriction site was particularly useful in the construction of E. coli vectors that express the mutated mecA-27r genes.
Initial expression vectors contained a thermal-inducible version of the APLpromoter for expression of foreign proteins (26, 33) . Analyses of cell extracts from transformants carrying truncated versions of mecA-27r in the A PLexpression system revealed the presence of new proteins of the predicted sizes. In most cases, virtually all of the modified PBP2a-27r was found in inclusion bodies (granules) when the thermally inducible A PL expression system was used to express the shortened versions of PBP2a-27r. The modified proteins from crude cell extracts, upon initial inspection, appeared to retain penicillinbinding activity on the basis of their interaction with 12511 penicillin V. An example of this binding is illustrated in Fig. 2A (right side) for extracts containing PBP2a-27r with 245 amino acids removed from the N terminus. However, even at high concentrations of cefamandole, no IC50 was formed with this truncated PBP2a-27r. A similar result was obtained when extracts from cells producing PBP2a-27r shortened by 144 or 341 amino acids were analyzed with the XPL expression system.
In contrast, an IC50 of between 90 and 180 ,ug of cefamandole per ml was estimated for wild-type PBP2a-27r obtained from S. aureus 27r ( Fig. 2A, left side) . The inability to detect an IC50
for the truncated forms of PBP2a-27r within the concentration range of cefamandole employed was inconsistent with binding of the radiolabeled penicillin to the active site of these proteins. Other experiments snot described here) suggested that nonspecific binding of 1 I-penicillin V was frequently associated with inclusion body or granule formation. protein present in inclusion bodies was full-length PBP2a-27r. Furthermore, purification of PBP2a-27r from inclusion bodies would require solubilization and subsequent refolding of the protein in an active form for structural studies. In an attempt to eliminate nonspecific background binding, achieve higher levels of PBP2a-27r expression, and avoid the need for complex unfolding-refolding experiments, alternative expression systems were examined in which inclusion bodies would not be formed or would at least be minimized. Expression of PBP2a-27r in baculovirus produced correctly folded soluble protein; however, the amount of the desired recombinant protein produced was insufficient for our purposes.
Alternative expression systems, utilizing either a B. subtilis vegetative promoter (veg) (19) or the E. coli lac promoter, allowed constitutive expression of modified mecA-27r genes at a lower temperature (25°C). With these expression systems, inclusion body formation could be avoided and analysis of truncated forms of PBP2a-27r was less complicated by the presence of nonspecific background binding of 125I-penicillin
V. An example of the results obtained when modified PBP2a-27r proteins were expressed in a soluble form is displayed in Fig. 2B . In this example, results obtained from Western blot analysis and a penicillin-binding assay with extracts from an E. coli transformant carrying plasmid pEWSA86 (lac promoter system) are displayed. Western blot analysis confirmed production of the shortened version of PBP2a-27r ( -144 amino acids [left side of Fig. 2B]) , and the penicillin-binding assay shown on the right side of Fig. 2B indicated the inability of this protein to bind penicillin. Similar analyses were performed for each of the shortened versions of PBP2a-27r. Figure 3 (20) . By comparison, the distance between the SXXK and SXN motifs in PBP2a-27r is 61 amino acids, and 195 amino acids lie between the SXXK and KSG motifs. Thus, the linear spacing of the conserved motifs within the primary structure of PBP2a-27r was consistent with those of other characterized PBPs.
The presence and appropriate spacing of these motifs do not verify their importance in PBP2a's interaction with beta-lactam antibiotics. Therefore, each of these motifs was altered by site-specific in vitro mutagenesis of the mecA-27r gene, and the resulting modified PBP2a-27r proteins were tested for penicillin-binding activity.
Site-specific mutagenesis of the conserved motifs within the mec4-27r gene altered penicillin-binding activity. To Superscripts: 1, plasmid carries the native S. aureus promoter for mecA-27r; 2, plasmid carries the veg promoter from B. subtilis, the mecA-27r gene has been modified to remove the transmembrane regionn, and a chelating peptide has been added to PBP2a-27r.
analysis, and then penicillin-binding activity was assessed (Fig.  6 ). Both mutations (i.e., S-463--->C-463 and N-465-->Q-465) rendered PBP2a-27r incapable of binding penicillin. It should be noted that another serine residue is present immediately before S-463. In another experiment (results not shown), S-462 was changed to K-462. Lysine was chosen because PBP3 of E.
coli has a lysine residue in the analogous position. Analysis of PBP2a-27r carrying the S-462-->K-462 alteration revealed no change in its capacity to bind penicillin.
Finally, the results of altering the KSG motif (amino acids 597--599) are illustrated in Fig. 7 . In this experiment, S-598 of PBP2a-27r was changed to C-598. The mutated mecA-27r gene was subcloned into plasmid pEWSA64 (Fig. 4) . Extracts from two E. coli transformants carrying pEWSA64 were examined for the effect the mutations had on PBP2a-27r. Western blot analysis, summarized at the bottom of Fig. 7 , once again confirmed expression of the modified PBP2a-27r in these transformants. Assessment of penicillin-binding activity revealed that the S-598-->C-598 alteration in the KSG motif eliminated penicillin binding in this modified form of PBP2a-27r. Penicillin-binding results for all five of the mutations described above are summarized on the right side of Fig. 4 . 
DISCUSSION
The interactions of beta-lactam antibiotics with PBPs involved in bacterial cell wall biosynthesis have been studied extensively, yet a detailed understanding of these interactions at the molecular level remains unavailable. Ultimately, the resolution of these problems may require elucidation of the three-dimensional structural details of PBPs. Armed with such structural knowledge, significant advances could be made in understanding how PBPs interact with beta-lactams. PBP2a represents an intriguing target in such studies because its presence in the staphylococci causes significant clinical problems. A detailed understanding of the interaction of PBP2a with beta-lactam antibiotics may provide critical information for the design of new antibiotics effective in combating the rising incidence of methicillin resistance.
Removal of the transmembrane region of PBP2a-27r, which anchors this protein to the exterior of the cell membrane as an ectoprotein, did not significantly alter penicillin-binding activity (33) . Several other modifications made to the mecA-27r gene to examine the role of various regions and motifs in penicillin binding are described in this report. Substitution of a shorter metal-chelating peptide in the position previously occupied by the transmembrane region also caused no detectable alteration in penicillin-binding activity in the modified PBP2a-27r. This modified form of PBP2a-27r was rapidly recovered from E. coli extracts (-95% pure) by chelating peptide-immobilized metal affinity chromatography in a single step (unpublished result). Conventional protein purification procedures required several steps to achieve this purity. Rapid purification of an active form of PBP2a-27r will facilitate structural analysis of this protein by X-ray crystallography.
DNA sequence comparisons with other PBPs have sug- gested that PBP2a is composed of two domains (25, 28) , with the penicillin-interactive domain occupying the carboxyl region of the protein. Crystallization of only the penicillin-interactive domain might prove more successful because of the large size of the intact protein (-76 kDa). However, deletion analyses of the putative transglycosylase domain demonstrated that this region was also essential for penicillin-binding activity. Consequently, crystallization of a shortened version of PBP2a-27r was not an option.
Analyses of amino acid sequences from PBPs and betalactamases have revealed conservation of certain amino acid motifs in the penicillin-interacting portion or putative transpeptidase domains of these enzymes (9, 18, 20) . Crystallography data indicated that when these penicillin-interacting enzymes assume their native structure, these motifs are brought into close proximity within the active-site cleft, where substrate-enzyme inhibitor interactions occur (22, 29) . Such observations have led to the suggestion that beta-lactamases and PBPs share a common ancestry (9) . The motifs of particular interest include SXXK, SXN, and KSG.
PBP2a-27r contains key active-site motifs of beta-lactamases and PBPs in the carboxyl half of the protein, which represents the presumed transpeptidase domain. In addition to the presence of these motifs and localized sequence conservation surrounding them, the linear spacing between motifs in PBP2a-27r was consistent with the spacing of the same motifs in PBPs from E. coli. Analysis of PBP2a from E. coli verified that the serine residue found within the SXXK motif of that enzyme was the site of acylation by beta-lactams (30) . On the basis of sequence homology with other PBPs, Song and colleagues (28) suggested that S-403 of PBP2a, within the SXXK motif, may be the site of acylation by beta-lactams. The site-specific in vitro mutagenesis described herein illustrates the importance of the SXXK motif in PBP2a-27r. When the S-403-->C-403 mutation was induced in PBP2a-27r, penicillin-binding activity was no longer detectable, consistent with the suggestion that S-403 may be the site of acylation by beta-lactams. Evidence from X-ray crystallography of DD-carboxypeptidase and a class C beta-lactamase indicated that the lysine of the SXXK motif and the lysine of the KSG motif interact through hydrogen bonding with beta-lactams, perhaps coordinating its position within the active-site cleft (11, 22) . When lysine was changed to arginine in the SXXK motif in a class A beta-lactamase from Streptomyces albus, the rate constant of acylation was greatly reduced (4). When K-406 was changed to R-406 in PBP2a-27r, penicillin-binding activity was lost once again. Loss of penicillin-binding activity when K-406 was changed to another basic amino acid (R-406) in the SXXK motif of PBP2a-27r suggests a very specific spatial requirement for the positive charge of lysine in its interaction with beta-lactams.
It has been argued that the KSG motif in combination with the lysine residue of the SXXK motif forms a hydrogenbonding network that coordinates the position of the C-3 carboxyl group of beta-lactams (11, 22) . The precise function of the SXN motif remains to be elucidated, although homology with beta-lactamases suggests that it is involved in deacylation of a bound beta-lactam (22) . Alterations of the SXN and KSG motifs of PBP2a-27r also resulted in a loss of penicillin-binding activity, providing evidence that these motifs are intimately involved in the interaction of beta-lactams with PBP2a-27r. It should be noted that a number of other mutations which altered the amino acid sequence of PBP2a, made in vitro or observed in mecA genes of other clinical isolates of S. aureus, did not alter penicillin-binding activity (data not shown).
These results demonstrate that the putative transpeptidase domain of PBP2a-27r interacts directly with beta-lactam molecules at the anticipated sites predicted from previous work on penicillin-interactive enzymes. However, unequivocal demonstration of PBP2a's capacity to synthesize cell wall remains to be seen, and its reduced affinity for beta-lactam antibiotics remains a mystery.
